Rosetta Genomics Ltd. To Host Business Update And 2014 Year End Financials Conference Call On March 17, 2015

PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that following the close of the U.S. stock market on Monday, March 16, 2015, the Company will file its financial results for the year ended December 31, 2014 on Form 20-F with the U.S. Securities and Exchange Commission (“SEC”). The Form 20-F includes audited consolidated financial statements, as well as additional information regarding the Company. Once filed, the Form 20-F will be available at www.sec.gov and at www.rosettagenomics.com.

Help employers find you! Check out all the jobs and post your resume.

Back to news